PATENT CLAIM ANALYSIS

Application Number: 15747827
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "023000"]

Abstract:
An object of the present invention is to provide a GLP-1 secretagogue which is an incretin hormone-related drug relatively inexpensive, excellent in safety, and capable of promoting GLP-1 secretion without containing sucrose as an essential constituent. The object is achieved by a GLP-1 secretagogue characterized by containing D-psicose as an active ingredient.

Claim (Index 12):
The method according to  claim 7 , wherein the GLP-1 secretagogue is administered to the subject a GLP-1 secretagogue composition comprising D-psicose as a GLP-1 secretagogue and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11909493', '12932633', '14908210', '13276177', '12594568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6973197556354699
- 35 USC 102 Novelty (BERT): 0.5255364649901971
- Combined Prediction Score: 0.6801414265709427
- Mean Citation Score: 250.013846
- Max Citation Score: 303.8514
- Similarity Product: 168.90533586137298

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test